Skip to main content
PolicySpeak
← All files
SER

Servier

Company · France · EU Transparency Register 18370091485-91

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #853 by legislative files engaged — a count of participation, not a measure of influence.

0.8
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2009
in the register since

Declares membership of

  • Servier is a member of EFPIA (European Federation of Pharmaceutical Industries and Associations), of the GIRP (the Eu…

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Head office
Suresnes, France
EU office
Anderlecht

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Servier in PolicySpeak: request access →

Work at Servier? so we know who speaks for it.

Follow the file Servier engages with

One email on Tuesdays when a new position is filed on this file, from Servier or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Servier filed 1 position on 27 Jul 2026, across 1 of the 326 legislative files tracked here.

What they argued

European Biotech Actfiled 27 Jul 2026source

Servier, an independent international pharmaceutical group focusing on oncology, neurology and cardio-metabolic diseases, welcomes this public consultation. Our unique governance as an independent company governed by a non-profit Foundation allows us to maintain a long-term vision focused solely on therapeutic progress and patient needs.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Servier’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.